MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.wneu.2023.09.076

Медицинская библиотека · World neurosurgery · 2023

Crooke Cell Adenoma Confers Poorer Endocrinological Outcomes Compared with Corticotroph Adenoma: Results of a Multicenter, International Analysis.

Findlay Matthew C, Drexler Richard, Azab Mohammed, Karbe Arian, Rotermund Roman, Ricklefs Franz L, Flitsch Jörg, Smith Timothy R, Kilgallon John L, Honegger Jürgen, Nasi-Kordhishti Isabella, Gardner Paul A, Gersey Zachary C, Abdallah Hussein M, Jane John A, Marino Alexandria C, Knappe Ulrich J, Uksul Nesrin, Rzaev Jamil A, Bervitskiy Anatoliy V, Schroeder Henry W S, Eördögh Márton, Losa Marco, Mortini Pietro, Gerlach Rüdiger, Antunes Apio C M, Couldwell William T, Budohoski Karol P, Rennert Robert C, Karsy Michael

Систематический обзорСтатьяПеревод в очереди

Аннотация

BACKGROUND

Crooke cell adenomas (CCAs) are a rare, aggressive subset of secretory pituitary corticotroph adenomas (sCTAs) found in 5%-10% of patients with Cushing disease. Multiple studies support worse outcomes in CCAs but are limited by small sample size and single-institution databases. We compared outcomes in CCA and sCTA using a multicenter, international retrospective database of high-volume skull base centers.

METHODS

Patients surgically treated for pituitary adenoma from January 2017 through December 2020 were included.

RESULTS

Among 2826 patients from 12 international centers, 20 patients with CCA and 480 patients with sCTA were identified. No difference in baseline demographics, tumor characteristics, or postoperative complications was seen. Microsurgical approaches (60% CCA vs. 62.3% sCTA) were most common. Gross total resection was higher in CCA patients (100% vs. 83%, P = 0.05). Among patients with gross total resection according to intraoperative findings, fewer CCA patients had postoperative hormone normalization of pituitary function (50% vs. 77.8%, P < 0.01) and remission of hypersecretion by 3-6 months (75% vs. 84.3%, P < 0.01). This was the case despite CCA having better local control rates (100% vs. 96%, P < 0.01) and fewer patients with remnant on magnetic resonance imaging (0% vs. 7.2%, P < 0.01). A systematic literature review of 35 studies reporting on various treatment strategies reiterated the high rate of residual tumor, persistent hypercortisolism, and tumor-related mortality in CCA patients.

CONCLUSIONS

This modern, multicenter series of patients with CCA reflects their poor prognosis and reduced postsurgical hormonal normalization. Further work is necessary to better understand the pathophysiology of CCA to devise more targeted treatment approaches.

Для цитирования: Findlay Matthew C, Drexler Richard, Azab Mohammed, Karbe Arian, Rotermund Roman, Ricklefs Franz L, Flitsch Jörg, Smith Timothy R, Kilgallon John L, Honegger Jürgen, Nasi-Kordhishti Isabella, Gardner Paul A, Gersey Zachary C, Abdallah Hussein M, Jane John A, Marino Alexandria C, Knappe Ulrich J, Uksul Nesrin, Rzaev Jamil A, Bervitskiy Anatoliy V, Schroeder Henry W S, Eördögh Márton, Losa Marco, Mortini Pietro, Gerlach Rüdiger, Antunes Apio C M, Couldwell William T, Budohoski Karol P, Rennert Robert C, Karsy Michael. Crooke Cell Adenoma Confers Poorer Endocrinological Outcomes Compared with Corticotroph Adenoma: Results of a Multicenter, International Analysis.. World neurosurgery. 2023. DOI: 10.1016/j.wneu.2023.09.076.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.